We are live on ! Find out more
VMD icon

Viemed Healthcare

88 hedge funds and large institutions have $218M invested in Viemed Healthcare in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,700% more call options, than puts

Call options by funds: $280K | Put options by funds: $10K

112% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 17

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

44% more capital invested

Capital invested by funds: $151M → $218M (+$66.4M)

10% more funds holding

Funds holding: 8088 (+8)

5.22% more ownership

Funds ownership: 53.37%58.6% (+5.2%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
88
Holders Change
+8
Holders Change %
+10%
% of All Funds
1.4%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
17
Increased
36
Reduced
17
Closed
9
Calls
$280K
Puts
$10K
Net Calls
+$270K
Net Calls Change
-$240K

VMD Hedge Fund Activity: Q1 2023 in Review

88 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q1 2023, worth a combined $218M — up 44% from $151M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new VMD positions and 9 closed out — a net gain of 8 holders — while 36 added to existing stakes and 17 trimmed.

The largest buyer was Triasima Portfolio Management, opening a new position worth an estimated $5.17M. The largest seller was EAM Global Investors, cutting an estimated $2.49M.

  • 88 institutional investors held Viemed Healthcare (VMD) as of Q1 2023, up from 80 in Q4 2022.
  • Funds reported $218M of Viemed Healthcare stock for Q1 2023, up 44% quarter-over-quarter.
  • 17 funds opened new Viemed Healthcare positions in Q1 2023 and 9 closed out, a net change of +8 holders.
  • The largest Viemed Healthcare buyer in Q1 2023 was Triasima Portfolio Management, an estimated $5.17M added.
  • The largest Viemed Healthcare seller in Q1 2023 was EAM Global Investors, an estimated $2.49M sold.

Based on aggregated 13F filings for Q1 2023.